{"id":409,"date":"2026-04-02T06:25:08","date_gmt":"2026-04-02T06:25:08","guid":{"rendered":"https:\/\/yashodahealthcare.com\/blogs\/multiple-myeloma-signs-stages-treatment\/"},"modified":"2026-04-02T06:25:08","modified_gmt":"2026-04-02T06:25:08","slug":"multiple-myeloma-signs-stages-treatment","status":"publish","type":"post","link":"https:\/\/yashodahealthcare.com\/blogs\/multiple-myeloma-signs-stages-treatment\/","title":{"rendered":"Multiple Myeloma: Signs, Stages, and Treatment Explained"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Multiple myeloma is a condition in which healthy plasma cells become cancerous, multiply and<br>produce abnormal antibodies called M protein. Plasma cells are a type of white blood cells that make<br>antibodies to fight infection. With multiple myeloma, plasma cells develop errors and build up in the<br>bone marrow. It is a rare condition of blood cancer that targets the plasma cells.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-signs-and-symptoms-of-multiple-myeloma\">Signs and symptoms of multiple myeloma:<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The most common symptom is pain in bones (back, head, chest or pelvis). Fatigue and weakness,<br>frequently falling sick, numbness in limbs, unexplained weight loss, nausea and vomiting are other<br>signs of multiple myeloma.<br>While the exact causes of multiple myeloma are medically unclear, the root tends to point towards<br>some gene mutation in the plasma cells. There are certain risk factors that lead to it:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Obesity<\/li>\n\n\n\n<li>Environmental toxins like pesticides or fertilisers<\/li>\n\n\n\n<li>Multiple myeloma affects more males than females and more common in middle to old age<br>group people<\/li>\n\n\n\n<li>Family history of multiple myeloma<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-stages-of-multiple-myeloma\">Stages of multiple myeloma:<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Multiple myeloma is staged between 1 to 3, depending upon the aggressiveness and severity of the<br>disease. The stage is determined by blood tests (beta-2 microglobulin, albumin, LDH), chromosome<br>analysis, and imaging in patients. This is to assess the burden of tumour present. Higher stages<br>indicate more aggressive and rapid growth of cancer cells.<br><strong>Stage 1<\/strong> is categorised with lower levels of beta-2 microglobulin and relatively normal albumin levels,<br>indicating a slower growth<br><strong>Stage 2<\/strong> has intermediate levels of beta-2 microglobulin and lower albumin levels<br><strong>Stage 3<\/strong> has higher levels of beta-2 microglobulin which indicates that the growth is rapid and disease<br>has become aggressive. This calls for an immediate intervention<br>Several tests are conducted to diagnose multiple myeloma and asses what stage the patient is at \u2013<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Blood tests are done to check for lower blood count or presence of abnormal antibodies like<br>M protein. They may also indicate any signs of tumour<\/li>\n\n\n\n<li>High levels of protein in urine is also an indicator of multiple myeloma, hence urine tests also<br>become important<\/li>\n\n\n\n<li>Imaging tests such as X-rays, CT scan, MRI, PET scan can also reveal tumours or abnormal<br>plasma cells<\/li>\n\n\n\n<li>Bone marrow biopsy is conducted to test the bone marrow tissue and check for signs of<br>myeloma<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-treatment-of-multiple-myeloma\">Treatment of multiple myeloma<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Once the results from these tests arrive and the oncologist determines the stage of multiple<br>myeloma, treatment procedures and planned and mapped out \u2013<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Stem cell transplant<\/strong> \u2013 Damaged and unhealthy stem cell tissues are replaced with healthy<br>ones. Stem cells enable the production of healthy new plasma cells in the bone marrow.<\/li>\n\n\n\n<li><strong>Chemotherapy<\/strong> is a drug-induced therapy that reduce the abnormal plasma cells. It is often<br>done before stem cell transplant for an effective result. Radiation in addition with<br>chemotherapy kills cancer cells<\/li>\n\n\n\n<li><strong>Immunotherapy <\/strong>helps the immune system develop more cancer-fighting cells<\/li>\n\n\n\n<li><strong>Targeted therapy<\/strong> targets specific weakness in plasma cells and kills them<\/li>\n\n\n\n<li><strong>High doses of steroids<\/strong> can also kill cancer cells and reduce inflammation<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/www.yashodahealthcare.com\/yashoda-cancer-institute\">Yashoda Superspeciality Hospital &amp; Cancer Institutes, Sanjay Nagar, Ghaziabad<\/a><\/strong>, has a highly-skilled<br>network of oncologists to treat patients with multiple myeloma.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/www.yashodahealthcare.com\/doctor\/maj-gen-b-n-kapur\">Dr. (Maj. Gen.) B.N. Kapur<\/a><\/strong>, the Director of Medical Oncology at Yashoda Superspeciality Hospital &amp;<br>Cancer Institutes, is one of the best oncologists in Delhi NCR. Former Indian Army Medical<br>Oncologist, he is a recipient of the Vishisht Sewa Medal (VSM), an accolade for his dedicated services<br>which he received from the President of India. Dr. (Maj. Gen.) B.N. Kapur specialises in bone marrow<br>transplant, hematolymphoid malignancy, paediatric tumour, and all solid tumours including all kinds<br>of blood cancers. He is also skilled in treating solid organ cancers using latest evidence-based<br>therapies and has a number of publications in his name.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For bookings and appointments-related query, please call us at our toll-free number \u2013<br>9810709038\/0120-4612000.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Multiple myeloma is a condition in which healthy plasma cells become cancerous, multiply andproduce abnormal antibodies called M protein. Plasma cells are a type of white blood cells that makeantibodies to fight infection. With multiple myeloma, plasma cells develop errors and build up in thebone marrow. It is a rare condition of blood cancer that&#8230;<\/p>\n","protected":false},"author":1,"featured_media":410,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28],"tags":[],"class_list":["post-409","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer-treatment"],"_links":{"self":[{"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/posts\/409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/comments?post=409"}],"version-history":[{"count":0,"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/posts\/409\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/media\/410"}],"wp:attachment":[{"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/media?parent=409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/categories?post=409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/yashodahealthcare.com\/blogs\/wp-json\/wp\/v2\/tags?post=409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}